Knowledge Management System of Northwest Institute of Plateau Biology, CAS
DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo | |
Li, Meng-yuan ; Lv, Yong-cong ; Tong, Lin-jiang ; Peng, Ting ; Qu, Rong ; Zhang, Tao ; Sun, Yi-ming ; Chen, Yi ; Wei, Li-xin ; Geng, Mei-yu ; Duan, Wen-hu ; Xie, Hua ; Ding, Jian | |
2016-03-01 | |
发表期刊 | ACTA PHARMACOLOGICA SINICA
![]() |
摘要 | Aim: Targeting the VEGF/VEGF receptor (VEGFR) pathway has proved to be an effective antiangiogenic approach for cancer treatment. Here, we identified 6-((2-((3-acetamidophenyl)amino)pyrimidin-4-yl)oxy)-N-phenyl-1-naphthamide (designated herein as DW10075) as a novel and highly selective inhibitor of VEGFRs. |
文献类型 | 期刊论文 |
条目标识符 | http://210.75.249.4/handle/363003/17429 |
专题 | 中国科学院西北高原生物研究所 |
推荐引用方式 GB/T 7714 | Li, Meng-yuan,Lv, Yong-cong,Tong, Lin-jiang,et al. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo[J]. ACTA PHARMACOLOGICA SINICA,2016. |
APA | Li, Meng-yuan.,Lv, Yong-cong.,Tong, Lin-jiang.,Peng, Ting.,Qu, Rong.,...&Ding, Jian.(2016).DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.ACTA PHARMACOLOGICA SINICA. |
MLA | Li, Meng-yuan,et al."DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo".ACTA PHARMACOLOGICA SINICA (2016). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论